Td Private Client Wealth LLC Gilead Sciences, Inc. Transaction History

Td Private Client Wealth LLC

  • $3.48 Trillion
  • Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 57,509 shares of GILD stock, worth $5.43 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
57,509
Previous 52,012 10.57%
Holding current value
$5.43 Million
Previous $3.57 Billion 35.11%
% of portfolio
0.14%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024
BUY
$66.59 - $83.99 $366,045 - $461,693
5,497 Added 10.57%
57,509 $4.82 Billion
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $3.28 Million - $3.79 Million
52,012 New
52,012 $3.57 Billion
Q1 2024

Aug 16, 2024
BUY
$71.58 - $87.29 $967,403 - $1.18 Million
13,515 Added 34.3%
52,921 $3.88 Billion
Q4 2023

Aug 16, 2024
SELL
$73.27 - $83.09 $252,415 - $286,245
-3,445 Reduced 8.04%
39,406 $3.19 Billion
Q3 2023

Aug 16, 2024
BUY
$73.94 - $80.67 $61,813 - $67,440
836 Added 1.99%
42,851 $3.21 Billion
Q2 2023

Aug 16, 2024
SELL
$76.01 - $86.7 $1.63 Million - $1.86 Million
-21,401 Reduced 33.75%
42,015 $3.24 Billion
Q1 2023

Aug 16, 2024
SELL
$77.31 - $88.08 $3.77 Million - $4.29 Million
-48,704 Reduced 43.44%
63,416 $5.26 Billion
Q4 2022

Aug 16, 2024
SELL
$62.32 - $89.47 $1.3 Million - $1.86 Million
-20,795 Reduced 15.65%
112,120 $9.63 Billion
Q3 2022

Aug 16, 2024
BUY
$59.54 - $68.01 $699,833 - $799,389
11,754 Added 9.7%
132,915 $8.2 Billion
Q2 2022

Aug 16, 2024
BUY
$57.72 - $65.01 $846,059 - $952,916
14,658 Added 13.76%
121,161 $7.49 Billion
Q1 2022

Aug 16, 2024
BUY
$57.92 - $72.58 $902,277 - $1.13 Million
15,578 Added 17.13%
106,503 $6.33 Billion
Q4 2021

Aug 16, 2024
SELL
$64.88 - $73.64 $1.13 Million - $1.29 Million
-17,491 Reduced 16.13%
90,925 $6.6 Billion
Q3 2021

Aug 16, 2024
BUY
$67.69 - $73.03 $3.82 Million - $4.12 Million
56,404 Added 108.44%
108,416 $7.57 Billion
Q2 2021

Aug 16, 2024
BUY
$63.47 - $69.35 $1.82 Million - $1.98 Million
28,610 Added 36.36%
107,300 $7.39 Billion
Q1 2021

Aug 16, 2024
SELL
$60.0 - $68.46 $162,720 - $185,663
-2,712 Reduced 3.33%
78,690 $5.09 Billion
Q4 2020

Aug 16, 2024
BUY
$56.65 - $64.55 $878,018 - $1 Million
15,499 Added 23.52%
81,402 $4.74 Billion
Q3 2020

Aug 16, 2024
BUY
$62.1 - $78.08 $2.14 Million - $2.69 Million
34,388 Added 109.12%
65,903 $4.16 Billion
Q2 2020

Aug 16, 2024
SELL
$72.34 - $84.0 $3.41 Million - $3.96 Million
-47,202 Reduced 59.96%
31,515 $2.42 Billion
Q1 2020

Aug 16, 2024
BUY
$62.63 - $80.22 $350,101 - $448,429
5,590 Added 7.64%
78,717 $5.88 Billion
Q4 2019

Aug 16, 2024
BUY
$61.62 - $67.78 $1.3 Million - $1.43 Million
21,115 Added 40.6%
73,127 $4.75 Billion

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email